Bethesda, MD, United States of America

Christopher E Walsh

This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher E Walsh. Retrieved from https://idiyas.com/inventor/christopher-e-walsh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 132(Granted Patents)


Company Filing History:

goldMedal2 out of 834,453 
Other
 patents

Years Active: 2001-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Christopher E Walsh

Introduction

Christopher E Walsh is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of gene therapy, particularly through his work with adeno-associated viruses. With a total of 2 patents, his inventions focus on delivering and expressing mammalian genes in a regulated manner.

Latest Patents

Walsh's latest patents include:

1. **Adeno-associated virus capable of expressing factor IX protein and cells comprising the same** - This invention concerns a recombinant adeno-associated virus vector that can deliver and express at least one mammalian gene into the genome of a mammalian host cell. The expression of the gene is regulated in a tissue-specific manner by cis-acting regulatory and promoter elements of the gene. A method for using this recombinant adeno-associated virus vector for therapeutic purposes is also provided.

2. **Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy** - Similar to the first patent, this invention also involves a recombinant adeno-associated virus vector capable of delivering and expressing mammalian genes. It emphasizes the regulation of gene expression in a tissue-specific manner and includes methods for therapeutic applications.

Career Highlights

Throughout his career, Walsh has focused on advancing gene therapy techniques. His innovative approaches have opened new avenues for treating genetic disorders and improving patient outcomes. His work is recognized for its potential impact on the medical field.

Collaborations

Walsh has collaborated with esteemed colleagues such as Richard Jude Samulski and Arthur W Nienhuis. These partnerships have contributed to the development and refinement of his groundbreaking inventions.

Conclusion

Christopher E Walsh is a prominent figure in the realm of gene therapy, with a focus on adeno-associated viruses. His patents reflect his commitment to advancing medical science and improving therapeutic methods. His contributions continue to influence the field and inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…